CJC-1295 DAC 化学特性,用途語,生産方法
説明
CJC-1295, also known as DAC:GRF, is a synthetic analogue of growth hormone-releasing hormone (GHRH). It is a modified form of GHRH (1-29) with improved pharmacokinetics, especially in regard to half-life. CJC-1295 has been shown to extend the half-life and bioavailability of growth-hormone-releasing hormone 1-29 and stimulate insulin-like growth factor 1 secretion. It increases the half-life of acting agents by bioconjugation.
定義
CJC-1295 DAC, which stands for (Drug Affinity Complex) is provided with 2mg of lyophilized powder. This is a 30 amino acid pharmaceutical-grade research peptide. Other peptides can be drawn into the same syringe to minimize the injections needed for desired testing. CJC-1295 DAC is essentially a peptide that boosts protein synthesis. To be clear, what is considered normal CJC-1295 without DAC is a misnamed Mod GRF. When the peptide does not contain DAC, it is no longer considered CJC, which can be confusing to many. Mod GRF is a terasubstituted peptide of the modified version of the original GRF 1-29, commonly known as sermorelin.
利点
CJC-1295 offers many benefits to the body, including: Increased growth hormone secretion and IGF-1 Levels with no increase in prolactin. Increased Body Weight and Length through increased protein synthesis. Increased Muscle Growth.
CJC-1295 DAC 上流と下流の製品情報
原材料
準備製品